93315-49-2Relevant articles and documents
A novel quinoline derivative containing a phenanthroimidazole moiety: Synthesis, physical properties and light-emitting diodes application
Shao, Xiaona,Liu, Wenzhu,Guo, Ruike,Chen, Junfeng,Zhou, Nonglin
, (2021/02/09)
The deep-blue emitting material 2-(8-(benzyloxy)quinolin-2-yl)-1-phenyl-1H-phenanthro[9,10-d]imidazole (QL-PPI) which contains 8-(Benzyloxy)quinoline core and phenanthroimidazole moiety, has been designed and synthesized. The non-doped OLED using QL-PPI a
Synthesis and evaluation of clioquinol-rolipram/roflumilast hybrids as multitarget-directed ligands for the treatment of Alzheimer's disease
Hu, Jinhui,Pan, Tingting,An, Baijiao,Li, Zhengcunxiao,Li, Xingshu,Huang, Ling
, p. 512 - 526 (2019/01/03)
Considering the importance of PDE4D inhibition and the modulation of biometals in Alzheimer's disease (AD) therapeutics, we have designed, synthesized and evaluated a series of new clioquinol-rolipram/roflumilast hybrids as multitarget-directed ligands fo
Preparation of 8-hydroxyquinoline derivatives as potential antibiotics against Staphylococcus aureus
Lam, Kim-Hung,Gambari, Roberto,Lee, Kenneth Ka-Ho,Chen, Yi-Xin,Kok, Stanton Hon-Lung,Wong, Raymond Siu-Ming,Lau, Fung-Yi,Cheng, Chor-Hing,Wong, Wai-Yeung,Bian, Zhao-Xiang,Chan, Albert Sun-Chi,Tang, Johnny Cheuk-On,Chui, Chung-Hin
, p. 367 - 370 (2015/02/19)
This work describes the preparation of quinoline compounds as possible anti-bacterial agents. The synthesized quinoline derivatives show anti-bacterial activity towards Staphylococcus aureus. It is interesting to observe that the synthetic 5,7-dibromo-2-methylquinolin-8-ol (4) shows a similar minimum inhibitory concentration of 6.25 μg/mL as compared to that of methicillin (3.125 μg/mL) against Staphylococcus aureus.